期刊文献+

急性髓系白血病患者骨髓单个核细胞C-kit受体和CD_(56)表达及其与预后的关系

下载PDF
导出
摘要 应用流式细胞仪测定106例初治急性髓性白血病(AML)患者骨髓C-kit受体、CD56抗原的表达。结果C-kit受体、CD56阳性率分别为6 4.1 5%、1 6.9 8%,两者共表达者临床缓解率明显低于单独表达及两者均阴性表达者(P<0.0 5)。认为两者共表达可作为急性髓性白血病预后不良的判断指标。
出处 《山东医药》 CAS 北大核心 2007年第17期37-38,共2页 Shandong Medical Journal
  • 相关文献

参考文献8

二级参考文献15

  • 1刘杰文,Wynt.,Ed.人骨髓基质细胞中某些细胞因子和特异性标记的免疫电镜定位[J].中华血液学杂志,1995,16(12):619-622. 被引量:6
  • 2艾辉胜,现代白血病学,1997年,164页 被引量:1
  • 3张之南,血液病诊断及疗效标准,1991年,190页 被引量:1
  • 4Baer MR,Stewart CC, Lawrence D,etal. Expression of the neural cell adhesion molecule CD56 is associated with shortremission duration and survival in acute myeloid leukemia witht(8;21)[J].Blood,1997,90(4):1643-1648. 被引量:1
  • 5Mann KP, DeCastro CM,Liu J,et al. Neural cell adhesion molecule (CD56)-positiveacute myelogenous leukemia and myelodysplastic and myeloproliferative syndromes[J].Am JClin Pathol,1997,107(6):653-660. 被引量:1
  • 6Suzuki R,Yamamoto K,Seto M,et al.CD7+ and CD56+ myeloid/natural killer cellprecursor acute leukemia: a distinct hematolymphoid diseaseentity[J].Blood,1997,90(6):2417-2428. 被引量:1
  • 7Reuss-Borst MA, Jaschonek K, Mller CA. Acute undifferentiated leukemia with anunusual CD7+ CD56+ CD33+ immunophenotype of NK progenitor[J].Leukemia,1996,10(5):923-924. 被引量:1
  • 8Suzuki R, Nakamura S. Malignancies of natural killer(NK) cell precursor: myeloid/NKcell precursor acute leukemia and blastic NK cell lymphoma/leukemia [J]. LeukRes,1999,23(7):615-624. 被引量:1
  • 9Murray CK, Estey E, Paietta E, et al. CD56 expression in acute promyelocyticleukemia: a possible indicator of poor treatment outcome[J]? J ClinOncol,1999,17(1):293-297. 被引量:1
  • 10Scott AA, Head DR, Kopecky KJ,et al. HLA-DR-,CD33+,CD56+,CD16-myeloid/naturalkiller cell acute leukemia: a previously unrecognized form of acute leukemia potentiallymisdiagnosed as French-American-British acute myeloid leukemia-M3[J].Blood,1994,84(1):244-255. 被引量:1

共引文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部